Trial intelligence / Profile preview

HECICS: Heparin vs Citrate in Cell Salvage

NCT02674906Completed

Sponsor
Ziekenhuis Oost-Limburg
Start
Feb 2016
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of anticoagulant citrate dextrose solution A in intraoperative bleeding (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoints: Concentration of pro- and anti-inflammatory markers in the cell-free fraction of the centrifugate, Concentration of markers of oxidative stress in the cell-free fraction of the centrifugate and 1 more. Started Feb 2016; status: completed.

02

Drugs

anticoagulant citrate dextrose solution A
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on NCT02674906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02674906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call